DE983381T1 - Voraussage koronarer arterienerkrankung - Google Patents
Voraussage koronarer arterienerkrankungInfo
- Publication number
- DE983381T1 DE983381T1 DE0983381T DE98910298T DE983381T1 DE 983381 T1 DE983381 T1 DE 983381T1 DE 0983381 T DE0983381 T DE 0983381T DE 98910298 T DE98910298 T DE 98910298T DE 983381 T1 DE983381 T1 DE 983381T1
- Authority
- DE
- Germany
- Prior art keywords
- allele
- coronary artery
- artery disease
- seq
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 200000000007 Arterial disease Diseases 0.000 title 1
- 108700028369 Alleles Proteins 0.000 claims 44
- 238000000034 method Methods 0.000 claims 25
- 208000029078 coronary artery disease Diseases 0.000 claims 23
- 108020004414 DNA Proteins 0.000 claims 7
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 claims 5
- 102100039065 Interleukin-1 beta Human genes 0.000 claims 5
- 108091034117 Oligonucleotide Proteins 0.000 claims 5
- 239000013068 control sample Substances 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 238000012408 PCR amplification Methods 0.000 claims 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000012459 cleaning agent Substances 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 108091008053 gene clusters Proteins 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 238000003752 polymerase chain reaction Methods 0.000 claims 2
- 239000011535 reaction buffer Substances 0.000 claims 2
- 238000005070 sampling Methods 0.000 claims 2
- 102000000589 Interleukin-1 Human genes 0.000 claims 1
- 108010002352 Interleukin-1 Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 238000005194 fractionation Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/813,456 US6210877B1 (en) | 1997-03-10 | 1997-03-10 | Prediction of coronary artery disease |
| PCT/US1998/004725 WO1998040517A1 (en) | 1997-03-10 | 1998-03-09 | Prediction of coronary artery disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE983381T1 true DE983381T1 (de) | 2000-11-09 |
Family
ID=25212420
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69838250T Expired - Lifetime DE69838250T2 (de) | 1997-03-10 | 1998-03-09 | Voraussage koronarer arterienerkrankung |
| DE0983381T Pending DE983381T1 (de) | 1997-03-10 | 1998-03-09 | Voraussage koronarer arterienerkrankung |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69838250T Expired - Lifetime DE69838250T2 (de) | 1997-03-10 | 1998-03-09 | Voraussage koronarer arterienerkrankung |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6210877B1 (enExample) |
| EP (1) | EP0983381B1 (enExample) |
| JP (2) | JP4250765B2 (enExample) |
| CN (1) | CN100523214C (enExample) |
| AR (1) | AR011943A1 (enExample) |
| AT (1) | ATE370246T1 (enExample) |
| AU (1) | AU738875B2 (enExample) |
| BR (1) | BR9808313A (enExample) |
| CA (1) | CA2282746C (enExample) |
| DE (2) | DE69838250T2 (enExample) |
| DK (1) | DK0983381T3 (enExample) |
| EA (1) | EA199900813A1 (enExample) |
| ES (1) | ES2156843T3 (enExample) |
| GR (1) | GR20010300016T1 (enExample) |
| IL (1) | IL131745A0 (enExample) |
| MX (1) | MXPA99008223A (enExample) |
| NO (1) | NO994365L (enExample) |
| NZ (1) | NZ337642A (enExample) |
| PL (1) | PL335603A1 (enExample) |
| PT (1) | PT983381E (enExample) |
| WO (1) | WO1998040517A1 (enExample) |
| ZA (1) | ZA981937B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820383B2 (en) | 1997-03-10 | 2010-10-26 | Interleukin Genetics, Inc. | Method for diagnosing myocardial infarction |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6210877B1 (en) * | 1997-03-10 | 2001-04-03 | Interleukin Genetics, Inc. | Prediction of coronary artery disease |
| US6720141B1 (en) * | 1999-11-01 | 2004-04-13 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for restenosis |
| US6524795B1 (en) * | 1997-03-10 | 2003-02-25 | Interleukin Genetics, Inc. | Diagnostics for cardiovascular disorders |
| GB9711040D0 (en) * | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
| US20050282198A1 (en) * | 1997-05-29 | 2005-12-22 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype |
| US6437216B1 (en) | 1997-11-13 | 2002-08-20 | Interleukin Genetics Inc. | Transgenic models of inflammatory disease |
| GB9723835D0 (en) * | 1997-11-13 | 1998-01-07 | Nicklin Martin | Interleukin knockout |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| US20050032077A1 (en) * | 1998-03-10 | 2005-02-10 | Duff Gordon W. | Detecting genetic predisposition to sight-threatening diabetic retinopathy |
| IL139131A0 (en) * | 1998-04-21 | 2001-11-25 | Interleukin Genetics Inc | Fetal testing for prediction of low birth weight |
| US6733967B1 (en) | 1998-04-21 | 2004-05-11 | Interleukin Genetics, Inc. | Fetal testing for prediction of low birth weight |
| US6251598B1 (en) * | 1998-10-30 | 2001-06-26 | Interleukin Genetics, Inc. | Methods for diagnosing sepsis |
| AU778975B2 (en) * | 1999-02-10 | 2004-12-23 | Interleukin Genetics, Inc. | Therapeutics and diagnostics based on an IL-1B mutation |
| EP1192277B1 (en) * | 1999-05-24 | 2008-08-06 | Interleukin Genetics, Inc. | Diagnosis of restenosis |
| JP2003508022A (ja) * | 1999-06-30 | 2003-03-04 | インターリューキン ジェネティックス インコーポレイテッド | Ｉｌ−１炎症性ハプロタイプと関連する病気の診断および治療方法 |
| JP2005500032A (ja) * | 2001-06-15 | 2005-01-06 | インターリューキン ジェネティックス インコーポレイテッド | 老化関連症状の早期発現を検出および治療する方法 |
| US20080311581A1 (en) * | 2001-11-19 | 2008-12-18 | David Wyllie | Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| AU2002359431A1 (en) * | 2001-11-19 | 2003-06-10 | Interleukin Genetics, Inc. | Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| EP1327639A1 (en) * | 2002-01-15 | 2003-07-16 | Bayer Ag | Prediction of cardiovascular disease by genetic polymorphisms in cardiovascular associated genes |
| KR100924468B1 (ko) * | 2002-01-25 | 2009-11-03 | 인터레우킨 제네틱스, 인코포레이티드 | Ｉｌ-1 유전자 집단 및 관련된 염증성 다형성과 일배체형 |
| US20070264645A1 (en) * | 2002-01-25 | 2007-11-15 | Kenneth Kornman | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| EP1549770B1 (en) * | 2002-09-30 | 2008-03-12 | Novartis AG | Methods to predict cholesterol elevations during immunosuppressant therapy |
| US20050053956A1 (en) * | 2002-11-13 | 2005-03-10 | Dietz Harry C. | Detection of a predisposition for the development of coronary artery disease |
| US20060204962A1 (en) * | 2003-02-03 | 2006-09-14 | Udo Stropp | Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| WO2004081186A2 (en) * | 2003-03-10 | 2004-09-23 | Applera Corporation | Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof |
| US20050287559A1 (en) * | 2004-05-07 | 2005-12-29 | Applera Corporation | Genetic polymorphisms associated with vascular, methods of detection and uses thereof |
| US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| US8105775B2 (en) * | 2005-10-25 | 2012-01-31 | Interleukin Genetics, Inc. | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| RU2310862C1 (ru) * | 2006-05-02 | 2007-11-20 | Государственное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" | Способ выявления риска развития ишемической болезни сердца |
| US7935498B2 (en) * | 2006-07-07 | 2011-05-03 | Siemens Healthcare Diagnostics Inc. | Methods for identifying patients with increased risk of an adverse cardiovascular event |
| CA2668722A1 (en) * | 2006-11-15 | 2008-05-22 | Interleukin Genetics, Inc. | The il-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same |
| US20090170105A1 (en) * | 2007-11-08 | 2009-07-02 | Interleukin Genetics, Inc. | Diagnostics for Aging-Related Dermatologic Disorders |
| US20100112570A1 (en) * | 2008-10-22 | 2010-05-06 | Interleukin Genetics, Inc. | Genetic Markers for Weight Management and Methods of Use Thereof |
| CN102747075B (zh) * | 2012-06-07 | 2014-07-23 | 中国医学科学院阜外心血管病医院 | 与冠心病相关的6号染色体易感区域标签单核苷酸多态性位点及其组成的单体型与应用 |
| JP2019503176A (ja) | 2016-01-12 | 2019-02-07 | インターロイキン ジェネティクス， インコーポレイテッド | 処置に対する応答を予測するための方法 |
| CN106202936A (zh) * | 2016-07-13 | 2016-12-07 | 为朔医学数据科技（北京）有限公司 | 一种疾病风险预测方法及系统 |
| US10329620B2 (en) | 2017-01-12 | 2019-06-25 | Cardioforecast Ltd. | Methods and kits for treating cardiovascular disease |
| CA3142662A1 (en) | 2019-06-06 | 2020-12-10 | Sitokine Limited | Compositions and methods for treating lung, colorectal and breast cancer |
| CN110277137B (zh) * | 2019-06-13 | 2022-03-18 | 南方医科大学顺德医院(佛山市顺德区第一人民医院) | 一种用于检测冠心病的基因芯片信息处理系统及方法 |
| WO2021028469A1 (en) | 2019-08-12 | 2021-02-18 | Sitokine Limited | Compositions and methods for treating cytokine release syndrome and neurotoxicity |
| WO2021205013A1 (en) | 2020-04-09 | 2021-10-14 | Sitokine Limited | Compositions and methods for treating covid-19 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4582788A (en) | 1982-01-22 | 1986-04-15 | Cetus Corporation | HLA typing method and cDNA probes used therein |
| US5110920A (en) | 1982-01-22 | 1992-05-05 | Cetus Corporation | HLA typing method and DNA probes used therein |
| US4623619A (en) | 1982-03-03 | 1986-11-18 | Nordisk Insulinlaboratorium | Method for the determination of liability in human individuals to develop atherosclerosis |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5268267A (en) | 1987-08-21 | 1993-12-07 | The General Hospital Corporation | Method for diagnosing small cell carcinoma |
| GB9301453D0 (en) * | 1993-01-26 | 1993-03-17 | Clonit Spa | Nucleotide proves |
| US5658729A (en) | 1994-10-11 | 1997-08-19 | The University Of British Columbia | Method, reagent and kit for evaluating susceptibility to premature atherosclerosis |
| US5686246A (en) | 1995-08-03 | 1997-11-11 | Kornman; Kenneth S. | Detecting genetic predisposition to periodontal disease |
| US5698399A (en) | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
| US6210877B1 (en) * | 1997-03-10 | 2001-04-03 | Interleukin Genetics, Inc. | Prediction of coronary artery disease |
-
1997
- 1997-03-10 US US08/813,456 patent/US6210877B1/en not_active Expired - Fee Related
-
1998
- 1998-03-06 ZA ZA9801937A patent/ZA981937B/xx unknown
- 1998-03-09 EA EA199900813A patent/EA199900813A1/ru unknown
- 1998-03-09 WO PCT/US1998/004725 patent/WO1998040517A1/en not_active Ceased
- 1998-03-09 AU AU64574/98A patent/AU738875B2/en not_active Ceased
- 1998-03-09 CN CNB988049155A patent/CN100523214C/zh not_active Expired - Fee Related
- 1998-03-09 JP JP53974098A patent/JP4250765B2/ja not_active Expired - Fee Related
- 1998-03-09 DE DE69838250T patent/DE69838250T2/de not_active Expired - Lifetime
- 1998-03-09 ES ES98910298T patent/ES2156843T3/es not_active Expired - Lifetime
- 1998-03-09 IL IL13174598A patent/IL131745A0/xx unknown
- 1998-03-09 NZ NZ337642A patent/NZ337642A/en unknown
- 1998-03-09 DE DE0983381T patent/DE983381T1/de active Pending
- 1998-03-09 BR BR9808313-9A patent/BR9808313A/pt not_active Application Discontinuation
- 1998-03-09 DK DK98910298T patent/DK0983381T3/da active
- 1998-03-09 CA CA002282746A patent/CA2282746C/en not_active Expired - Fee Related
- 1998-03-09 EP EP98910298A patent/EP0983381B1/en not_active Expired - Lifetime
- 1998-03-09 MX MXPA99008223A patent/MXPA99008223A/es unknown
- 1998-03-09 PL PL98335603A patent/PL335603A1/xx unknown
- 1998-03-09 AR ARP980101032A patent/AR011943A1/es unknown
- 1998-03-09 AT AT98910298T patent/ATE370246T1/de not_active IP Right Cessation
- 1998-03-09 PT PT98910298T patent/PT983381E/pt unknown
-
1999
- 1999-09-09 NO NO994365A patent/NO994365L/no unknown
-
2001
- 2001-04-30 GR GR20010300016T patent/GR20010300016T1/el unknown
-
2008
- 2008-10-29 JP JP2008277752A patent/JP2009077727A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820383B2 (en) | 1997-03-10 | 2010-10-26 | Interleukin Genetics, Inc. | Method for diagnosing myocardial infarction |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2156843T1 (es) | 2001-08-01 |
| ATE370246T1 (de) | 2007-09-15 |
| PL335603A1 (en) | 2000-05-08 |
| DE69838250T2 (de) | 2008-05-08 |
| AU738875B2 (en) | 2001-09-27 |
| EP0983381A1 (en) | 2000-03-08 |
| ES2156843T3 (es) | 2008-04-16 |
| EP0983381A4 (en) | 2004-05-12 |
| MXPA99008223A (es) | 2003-07-21 |
| JP2009077727A (ja) | 2009-04-16 |
| CN1255948A (zh) | 2000-06-07 |
| IL131745A0 (en) | 2001-03-19 |
| EP0983381B1 (en) | 2007-08-15 |
| NO994365L (no) | 1999-11-09 |
| JP2001514522A (ja) | 2001-09-11 |
| WO1998040517A1 (en) | 1998-09-17 |
| GR20010300016T1 (en) | 2001-04-30 |
| NO994365D0 (no) | 1999-09-09 |
| PT983381E (pt) | 2007-11-26 |
| AU6457498A (en) | 1998-09-29 |
| JP4250765B2 (ja) | 2009-04-08 |
| NZ337642A (en) | 2001-02-23 |
| BR9808313A (pt) | 2000-05-16 |
| CN100523214C (zh) | 2009-08-05 |
| CA2282746C (en) | 2009-02-24 |
| EA199900813A1 (ru) | 2000-06-26 |
| AR011943A1 (es) | 2000-09-13 |
| CA2282746A1 (en) | 1998-09-17 |
| DK0983381T3 (da) | 2007-12-17 |
| US6210877B1 (en) | 2001-04-03 |
| DE69838250D1 (de) | 2007-09-27 |
| ZA981937B (en) | 1999-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE983381T1 (de) | Voraussage koronarer arterienerkrankung | |
| DE69131233T2 (de) | Verfahren und reagens zum nachweis von spezifischen nukleotid-variationen | |
| DE60218182T2 (de) | Methoden um dns von verschiedenen individuen nachzuweisen | |
| US6140047A (en) | Method and kit for predicting susceptibility to asthma | |
| KR101176091B1 (ko) | 염색체 이상의 검출방법 | |
| US5766847A (en) | Process for analyzing length polymorphisms in DNA regions | |
| US6376191B1 (en) | Microarray-based analysis of polynucleotide sequence variations | |
| US20030148301A1 (en) | Method of detecting nucleotide polymorphism | |
| EP1241266A1 (en) | Method of detecting nucleotide polymorphism | |
| CA2374916A1 (en) | Diagnostics and therapeutics for cardiovascular disorders | |
| KR102235340B1 (ko) | 토종닭의 성장 형질을 예측하기 위한 snp 마커 세트 및 이의 용도 | |
| DE3880434T2 (de) | Diagnostische probe zum nachweis von praedisposition fuer diabetes typ 1. | |
| WO2005095640B1 (de) | Polymorphismen im nod2/card15 gen | |
| FR2793809B1 (fr) | Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede | |
| EP0647278B1 (en) | Method and system for molecular-biological diagnostics | |
| DE985052T1 (de) | Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten | |
| Agtmael et al. | Genes for left-handedness: how to search for the needle in the haystack? | |
| US20040121344A1 (en) | Method of detecting nucleotide polymorphism | |
| JP5301281B2 (ja) | 臓器特異的遺伝子、その同定方法およびその用途 | |
| US8334096B2 (en) | Methods and compositions related to arrhythmogenic right ventricular cardiomyopathy (ARVC) | |
| Gasparini et al. | First‐trimester prenatal diagnosis of cystic fibrosis using the polymerase chain reaction: Report of eight cases | |
| CA2400543A1 (en) | The involvement of the bdnf gene in mood disorders | |
| DE60308665T2 (de) | Genuntersuchungsverfahren zur beurteilung des risikos für das auftreten von glaukom | |
| KR102336624B1 (ko) | 돈육의 콜라겐 함량 예측용 마커 및 이의용도 | |
| DE10061279A1 (de) | Verfahren und Diagnose-Kit zur Bestimmung der Prädisposition für Herz-Kreislauf-Krankheiten und Arteriosklerose |